Skip to main content Skip to secondary navigation
Main content start
Associate Professor of Bioengineering

Drew Endy

Associate Professor of Bioengineering
Drew Endy is a bioengineer at Stanford University who studies and teaches synthetic biology. His goals are civilization-scale flourishing and a renewal of liberal democracy. Prof. Endy helped launch new undergraduate majors in bioengineering at both MIT and Stanford and also the iGEM — a global genetic-engineering “Olympics” enabling thousands of students annually. His past students lead companies like Ginkgo Bioworks and Octant. He is married to Christina Smolke CEO of Antheia the essential medicine company. Endy served on the US National Science Advisory Board for Biosecurity (NSABB) the Committee on Science Technology & Law (CSTL) the International Union for the Conservation of Nature’s (IUCN) Synthetic Biology Task Force and, briefly, the Pentagon’s Defense Innovation Board (DIB). He currently serves on the World Health Organization’s (WHO) Advisory Committee on Variola Virus Research. Esquire magazine recognized Drew as one of the 75 most influential people of the 21st century.


PhD, Dartmouth, Biotechnology & Biochemical Engineering (1998)
MS, Lehigh, Environmental Engineering (1994)
BS, Lehigh, Civil Engineering (1992)